4//SEC Filing
Henig Yair Steve 4
Accession 0001209191-10-046763
CIK 0001180262other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 2:33 PM ET
Size
17.9 KB
Accession
0001209191-10-046763
Insider Transaction Report
Form 4
Henig Yair Steve
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2010-09-15$13.64/sh+1,181$16,109→ 10,957 total - Disposition to Issuer
Common Stock
2010-09-15$59.11/sh−11,439$676,159→ 13,820 total - Exercise/Conversion
Stock Appreciation Rights
2010-09-15−15,000→ 6,500 totalExercise: $32.79Exp: 2016-03-27→ Common Stock (15,000 underlying) - Sale
Common Stock
2010-09-16$58.68/sh−4,044$237,302→ 9,776 total - Exercise/Conversion
Stock Appreciation Rights
2010-09-15−1,181→ 16,725 totalExercise: $13.64Exp: 2019-02-27→ Common Stock (1,181 underlying) - Sale
Common Stock
2010-09-15$58.63/sh−1,001$58,689→ 9,776 total - Disposition to Issuer
Common Stock
2010-09-15$59.11/sh−698$41,259→ 10,259 total - Exercise/Conversion
Common Stock
2010-09-15$32.79/sh+15,000$491,850→ 25,259 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2010.
- [F2]Consists of stock appreciation rights granted under the Herbalife Ltd. 2005 Stock Incentive Plan, of which 20% vested on February 27, 2010, another 20% will vest on February 27, 2011 and the remaining 60% will vest on February 27, 2012.
- [F3]Consists of stock appreciation rights granted under the Herbalife Ltd. 2005 Stock Incentive Plan, of which 20% vested on March 23, 2007, 20% vested on March 23, 2008 and the remaining 60% vested on March 7, 2009.
Documents
Issuer
HERBALIFE LTD.
CIK 0001180262
Entity typeother
Related Parties
1- filerCIK 0001434625
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 2:33 PM ET
- Size
- 17.9 KB